nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—ADRB3—Signaling Pathways—GNAS—bile duct cancer	0.000782	0.000782	CbGpPWpGaD
Epinephrine—SLC22A1—Transmission across Chemical Synapses—HRAS—bile duct cancer	0.00078	0.00078	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—MMP9—bile duct cancer	0.00078	0.00078	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—GNAS—bile duct cancer	0.000779	0.000779	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	0.000775	0.000775	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—GNAS—bile duct cancer	0.000769	0.000769	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—SMAD4—bile duct cancer	0.000767	0.000767	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—ERBB2—bile duct cancer	0.000764	0.000764	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—IL6—bile duct cancer	0.000757	0.000757	CbGpPWpGaD
Epinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.000756	0.000756	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—NOS2—bile duct cancer	0.000752	0.000752	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—PTGS2—bile duct cancer	0.000747	0.000747	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—GNAS—bile duct cancer	0.000727	0.000727	CbGpPWpGaD
Epinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.000724	0.000724	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—GNAS—bile duct cancer	0.000716	0.000716	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—GNAS—bile duct cancer	0.0007	0.0007	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—NRAS—bile duct cancer	0.000692	0.000692	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—NRAS—bile duct cancer	0.000689	0.000689	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—SLC5A5—bile duct cancer	0.00068	0.00068	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—bile duct cancer	0.000672	0.000672	CbGpPWpGaD
Epinephrine—PAH—Disease—HRAS—bile duct cancer	0.000667	0.000667	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—SLC5A5—bile duct cancer	0.000661	0.000661	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—GNAS—bile duct cancer	0.000651	0.000651	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—bile duct cancer	0.000643	0.000643	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—TGFB1—bile duct cancer	0.000643	0.000643	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—HRAS—bile duct cancer	0.000641	0.000641	CbGpPWpGaD
Epinephrine—PAH—Disease—IL6—bile duct cancer	0.000639	0.000639	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—GNAS—bile duct cancer	0.000636	0.000636	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—SLC5A5—bile duct cancer	0.000634	0.000634	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—EGFR—bile duct cancer	0.00063	0.00063	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—NRAS—bile duct cancer	0.00063	0.00063	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—EGFR—bile duct cancer	0.000628	0.000628	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—IDH2—bile duct cancer	0.000612	0.000612	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—HRAS—bile duct cancer	0.000598	0.000598	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—KRAS—bile duct cancer	0.000595	0.000595	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—KRAS—bile duct cancer	0.000593	0.000593	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—GNAS—bile duct cancer	0.000591	0.000591	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—NRAS—bile duct cancer	0.000581	0.000581	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—EGFR—bile duct cancer	0.000574	0.000574	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—NRAS—bile duct cancer	0.000567	0.000567	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—NRAS—bile duct cancer	0.000553	0.000553	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—KRAS—bile duct cancer	0.000542	0.000542	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—TGFB1—bile duct cancer	0.00054	0.00054	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—SLC5A5—bile duct cancer	0.000537	0.000537	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—ERBB2—bile duct cancer	0.000535	0.000535	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—EGFR—bile duct cancer	0.00053	0.00053	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—NRAS—bile duct cancer	0.00053	0.00053	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GNAS—bile duct cancer	0.000528	0.000528	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFBR2—bile duct cancer	0.000528	0.000528	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TGFB1—bile duct cancer	0.000527	0.000527	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—IDH1—bile duct cancer	0.000526	0.000526	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—IDH2—bile duct cancer	0.000523	0.000523	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GNAS—bile duct cancer	0.000514	0.000514	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—GNAS—bile duct cancer	0.000509	0.000509	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—HRAS—bile duct cancer	0.000506	0.000506	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—HRAS—bile duct cancer	0.000504	0.000504	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—EGFR—bile duct cancer	0.000504	0.000504	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—KRAS—bile duct cancer	0.0005	0.0005	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SMAD4—bile duct cancer	0.0005	0.0005	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GNAS—bile duct cancer	0.000492	0.000492	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TGFB1—bile duct cancer	0.000492	0.000492	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—KRAS—bile duct cancer	0.000488	0.000488	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—IL6—bile duct cancer	0.000484	0.000484	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—IL6—bile duct cancer	0.000482	0.000482	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFBR2—bile duct cancer	0.000481	0.000481	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFBR2—bile duct cancer	0.000477	0.000477	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—KRAS—bile duct cancer	0.000476	0.000476	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFBR2—bile duct cancer	0.000471	0.000471	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—GNAS—bile duct cancer	0.000464	0.000464	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HRAS—bile duct cancer	0.000461	0.000461	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—GNAS—bile duct cancer	0.00046	0.00046	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MMP9—bile duct cancer	0.000459	0.000459	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—KRAS—bile duct cancer	0.000456	0.000456	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SMAD4—bile duct cancer	0.000456	0.000456	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—GNAS—bile duct cancer	0.000454	0.000454	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SMAD4—bile duct cancer	0.000451	0.000451	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—IDH1—bile duct cancer	0.000449	0.000449	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SMAD4—bile duct cancer	0.000446	0.000446	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFBR2—bile duct cancer	0.000445	0.000445	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IL6—bile duct cancer	0.000441	0.000441	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFBR2—bile duct cancer	0.000438	0.000438	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—bile duct cancer	0.000434	0.000434	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—NRAS—bile duct cancer	0.00043	0.00043	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—GNAS—bile duct cancer	0.00043	0.00043	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—ERBB2—bile duct cancer	0.00043	0.00043	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—HRAS—bile duct cancer	0.000425	0.000425	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—GNAS—bile duct cancer	0.000423	0.000423	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SMAD4—bile duct cancer	0.000422	0.000422	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GNAS—bile duct cancer	0.000417	0.000417	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SMAD4—bile duct cancer	0.000415	0.000415	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—HRAS—bile duct cancer	0.000415	0.000415	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—NRAS—bile duct cancer	0.000407	0.000407	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—IL6—bile duct cancer	0.000407	0.000407	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—bile duct cancer	0.000405	0.000405	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—HRAS—bile duct cancer	0.000405	0.000405	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—IDH2—bile duct cancer	0.000403	0.000403	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TGFB1—bile duct cancer	0.0004	0.0004	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFBR2—bile duct cancer	0.000389	0.000389	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—HRAS—bile duct cancer	0.000387	0.000387	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—IL6—bile duct cancer	0.000387	0.000387	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TGFB1—bile duct cancer	0.000378	0.000378	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GNAS—bile duct cancer	0.000376	0.000376	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—EGFR—bile duct cancer	0.000371	0.000371	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—KRAS—bile duct cancer	0.00037	0.00037	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SMAD4—bile duct cancer	0.000369	0.000369	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MMP9—bile duct cancer	0.000368	0.000368	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFBR2—bile duct cancer	0.000362	0.000362	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—NRAS—bile duct cancer	0.00036	0.00036	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—KRAS—bile duct cancer	0.00035	0.00035	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GNAS—bile duct cancer	0.000349	0.000349	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—SLC5A5—bile duct cancer	0.000347	0.000347	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—IDH1—bile duct cancer	0.000347	0.000347	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SMAD4—bile duct cancer	0.000342	0.000342	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—bile duct cancer	0.000329	0.000329	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—NRAS—bile duct cancer	0.000328	0.000328	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—EGFR—bile duct cancer	0.000328	0.000328	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—NRAS—bile duct cancer	0.000327	0.000327	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—NRAS—bile duct cancer	0.000325	0.000325	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000325	0.000325	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—NRAS—bile duct cancer	0.000321	0.000321	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—HRAS—bile duct cancer	0.000315	0.000315	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—bile duct cancer	0.000311	0.000311	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—KRAS—bile duct cancer	0.00031	0.00031	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—NRAS—bile duct cancer	0.000304	0.000304	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TGFB1—bile duct cancer	0.000304	0.000304	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—EGFR—bile duct cancer	0.000299	0.000299	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—NRAS—bile duct cancer	0.000299	0.000299	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HRAS—bile duct cancer	0.000298	0.000298	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EGFR—bile duct cancer	0.000298	0.000298	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—SLC5A5—bile duct cancer	0.000296	0.000296	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—EGFR—bile duct cancer	0.000296	0.000296	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—EGFR—bile duct cancer	0.000293	0.000293	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL6—bile duct cancer	0.000285	0.000285	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—bile duct cancer	0.000284	0.000284	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—KRAS—bile duct cancer	0.000283	0.000283	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—KRAS—bile duct cancer	0.000281	0.000281	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—KRAS—bile duct cancer	0.00028	0.00028	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ERBB2—bile duct cancer	0.00028	0.00028	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	0.000278	0.000278	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—EGFR—bile duct cancer	0.000277	0.000277	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—KRAS—bile duct cancer	0.000276	0.000276	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—bile duct cancer	0.000276	0.000276	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—EGFR—bile duct cancer	0.000273	0.000273	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GNAS—bile duct cancer	0.00027	0.00027	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—NRAS—bile duct cancer	0.000266	0.000266	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—bile duct cancer	0.000264	0.000264	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HRAS—bile duct cancer	0.000264	0.000264	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—KRAS—bile duct cancer	0.000262	0.000262	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—KRAS—bile duct cancer	0.000257	0.000257	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ERBB2—bile duct cancer	0.000255	0.000255	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ERBB2—bile duct cancer	0.000253	0.000253	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—bile duct cancer	0.000252	0.000252	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—bile duct cancer	0.00025	0.00025	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ERBB2—bile duct cancer	0.000249	0.000249	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—NRAS—bile duct cancer	0.000247	0.000247	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—EGFR—bile duct cancer	0.000242	0.000242	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HRAS—bile duct cancer	0.00024	0.00024	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MMP9—bile duct cancer	0.00024	0.00024	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HRAS—bile duct cancer	0.000239	0.000239	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HRAS—bile duct cancer	0.000238	0.000238	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ERBB2—bile duct cancer	0.000236	0.000236	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HRAS—bile duct cancer	0.000235	0.000235	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ERBB2—bile duct cancer	0.000232	0.000232	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GNAS—bile duct cancer	0.00023	0.00023	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—bile duct cancer	0.00023	0.00023	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—bile duct cancer	0.000229	0.000229	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.000229	0.000229	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—KRAS—bile duct cancer	0.000229	0.000229	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—bile duct cancer	0.000228	0.000228	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—bile duct cancer	0.000225	0.000225	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EGFR—bile duct cancer	0.000225	0.000225	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—bile duct cancer	0.000224	0.000224	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HRAS—bile duct cancer	0.000222	0.000222	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HRAS—bile duct cancer	0.000219	0.000219	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—bile duct cancer	0.000219	0.000219	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—bile duct cancer	0.000217	0.000217	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—bile duct cancer	0.000214	0.000214	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NRAS—bile duct cancer	0.000213	0.000213	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—bile duct cancer	0.000213	0.000213	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—KRAS—bile duct cancer	0.000212	0.000212	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—bile duct cancer	0.000209	0.000209	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ERBB2—bile duct cancer	0.000206	0.000206	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—bile duct cancer	0.000202	0.000202	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—bile duct cancer	0.000199	0.000199	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—bile duct cancer	0.000198	0.000198	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—bile duct cancer	0.000194	0.000194	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NRAS—bile duct cancer	0.000194	0.000194	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—bile duct cancer	0.000194	0.000194	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NRAS—bile duct cancer	0.000192	0.000192	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ERBB2—bile duct cancer	0.000192	0.000192	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NRAS—bile duct cancer	0.00019	0.00019	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—bile duct cancer	0.000186	0.000186	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KRAS—bile duct cancer	0.000183	0.000183	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—bile duct cancer	0.000181	0.000181	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—bile duct cancer	0.00018	0.00018	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NRAS—bile duct cancer	0.00018	0.00018	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—bile duct cancer	0.000179	0.000179	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNAS—bile duct cancer	0.000178	0.000178	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—bile duct cancer	0.000177	0.000177	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—bile duct cancer	0.000177	0.000177	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NRAS—bile duct cancer	0.000177	0.000177	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—bile duct cancer	0.000176	0.000176	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—bile duct cancer	0.000175	0.000175	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—bile duct cancer	0.000173	0.000173	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—bile duct cancer	0.000173	0.000173	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KRAS—bile duct cancer	0.000167	0.000167	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—bile duct cancer	0.000167	0.000167	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KRAS—bile duct cancer	0.000165	0.000165	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—bile duct cancer	0.000164	0.000164	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—bile duct cancer	0.000164	0.000164	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—bile duct cancer	0.000164	0.000164	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KRAS—bile duct cancer	0.000163	0.000163	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—bile duct cancer	0.000163	0.000163	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—bile duct cancer	0.000161	0.000161	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NRAS—bile duct cancer	0.000157	0.000157	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—bile duct cancer	0.000156	0.000156	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KRAS—bile duct cancer	0.000155	0.000155	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KRAS—bile duct cancer	0.000152	0.000152	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—bile duct cancer	0.000149	0.000149	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—bile duct cancer	0.000148	0.000148	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—bile duct cancer	0.000147	0.000147	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NRAS—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—bile duct cancer	0.000145	0.000145	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—bile duct cancer	0.000145	0.000145	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—bile duct cancer	0.000143	0.000143	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—bile duct cancer	0.000142	0.000142	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—bile duct cancer	0.000141	0.000141	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—bile duct cancer	0.000137	0.000137	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—bile duct cancer	0.000136	0.000136	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—bile duct cancer	0.000136	0.000136	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—bile duct cancer	0.000135	0.000135	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KRAS—bile duct cancer	0.000135	0.000135	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—bile duct cancer	0.000135	0.000135	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—bile duct cancer	0.000133	0.000133	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—bile duct cancer	0.000133	0.000133	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—bile duct cancer	0.000131	0.000131	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—bile duct cancer	0.000129	0.000129	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—bile duct cancer	0.000126	0.000126	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KRAS—bile duct cancer	0.000126	0.000126	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—bile duct cancer	0.000124	0.000124	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—bile duct cancer	0.000124	0.000124	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—bile duct cancer	0.00012	0.00012	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—bile duct cancer	0.000115	0.000115	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—bile duct cancer	0.000112	0.000112	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—bile duct cancer	0.00011	0.00011	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—bile duct cancer	0.000107	0.000107	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—bile duct cancer	0.000102	0.000102	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—bile duct cancer	9.55e-05	9.55e-05	CbGpPWpGaD
